Latest Market News

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

Rural Funds Group reported a 17% revenue increase for the year ended June 2025, but net profit and total comprehensive income sharply declined. The dividend reinvestment plan remains suspended, signaling cautious investor sentiment.

Dart Mining NL’s DTMOC securities have been suspended from trading by the ASX due to non-compliance with key listing rules, raising questions about the company’s regulatory standing.

Diversified United Investment Limited has announced a fully franked ordinary dividend of AUD 0.09 per share for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan with no discount.

Diversified United Investment Limited reported a 5.4% rise in statutory profit to $38 million for FY2025, alongside a zero-debt position and a maintained fully franked dividend of 9 cents per share.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

Resolution Minerals has successfully uplisted to the OTCQB Market in the U.S., enhancing access for American investors without issuing new shares. This move aligns with its strategy to tap into growing demand for critical minerals, particularly antimony.

Accent Group reported steady FY25 sales of $1.62 billion with a slight dip in profits, while advancing its Sports Direct rollout and extending key brand agreements.

LaserBond Limited reported a solid 10.4% rise in net profit for FY25, supported by steady revenue growth and a strategic equity stake in Gateway Group. The company also declared a fully franked final dividend, signaling confidence in future earnings.

Accent Group Limited reported a modest revenue increase but a 3.1% decline in net profit for FY25 amid a tough retail environment. The company announced a strategic partnership with Frasers Group to launch Sports Direct in Australia and New Zealand, signaling a new growth avenue.

BCI Minerals has transitioned to full-scale operations at its Mardie Salt Project, marking a pivotal moment with strong construction progress, secured financing, and binding offtake agreements. The company remains on track for first salt shipment by late 2026.

Cynata Therapeutics has entered a five-year At-the-Market Subscription Agreement with Acuity Capital, enabling access to up to $7.5 million in standby equity capital with full discretion over timing and pricing.